Effect of flunixin meglumine and firocoxib on ex vivo cyclooxygenase activity in horses undergoing elective surgery.

This research focuses on comparing the effects of two drugs, flunixin meglumine and firocoxib, on cyclooxygenase (COX) activity in horses undergoing elective surgery, both in vitro and ex vivo. The study found that flunixin meglumine significantly reduced COX-1 activity, while firocoxib had COX-1-sparing effects.

Objective and methodology of the research

• The purpose of the study was to compare the effects of two nonsteroidal anti-inflammatory drugs (NSAIDs), flunixin meglumine and firocoxib, on the inhibition of cyclooxygenase (COX), an enzyme that plays a crucial role in inflammation. This was carried out both in vitro (outside a living organism) and ex vivo (in or on tissue from an organism, in an external environment).
• The experiment involved 12 healthy horses undergoing elective surgery that were divided into two groups. One group received flunixin meglumine and the other firocoxib. Four additional horses were used for in vitro experiments.
• COX activity was measured by analyzing indicators like thromboxane B2, prostaglandin E2, and prostaglandin E metabolites. Serum drug concentrations were measured using high-performance liquid chromatography, and an in vitro coagulation-induced thromboxane B2 assay was used to calculate drug concentration and COX-1 inhibition curves.

Findings of the research

• In the flunixin meglumine group, COX-1 activity was significantly reduced at 2 and 24 hours after NSAID administration compared to baseline activity.
• In contrast, in the firocoxib group, COX-1 activity was significantly greater than the flunixin meglumine group. This indicates firocoxib had a sparing effect on COX-1 ex vivo.
• The research did not find any significant change in COX-2 activity after surgery in either group.
• Bland-Altman analysis, which assesses agreement between two measurements, revealed poor agreement between in vitro and ex vivo measurement of COX-1 activity.

Conclusions of the research

• The research concludes that firocoxib has a sparing effect on COX-1 when compared with flunixin meglumine in horses that underwent elective surgery.
• The study also showed a poor correlation between in vitro and ex vivo measurements, indicating potential discrepancies between laboratory and real-life conditions.